Seriously, nobody wants to answer this question: Name something...anything...from Synta that a buyer would want to pay for!
There are so many Biotech pharma companies whose market cap is either $40 million or less and trading $1.5 - $4 range. (CANF, MCUR,OPXA,EYEG,SPHS,VSTM). I do not, i repeat i do not own any of these stock but their price ranges are so stable even with low market cap.
SNTA has market cap of $60-70 million range but the price is so undervalued. Management should come up with a positive news and boost the price. They should have aware of the complexity prior to suspending Ganetespib from Phase 3.
You can't live in the past. The way things were a year ago are not the way they are now.
Everyone makes mistakes. All you can do is make the best of the situation, learn from it, and move on. That's what successful people do.
You too should consider yourself thankful for being able to sell shares of this worthless company for over 40 cents apiece.
Bruce thanks me for buying his shares at 44 cents, while he bought his shares at 1.74, 2....3....Bruce and You are stupid or I am stupid? I think your head are full of poo......
How about you? you're stupid or not? If you aren't stupid, why you are still here? #$%$!!!!!
They are selling to recoup some money or
They might need a lose to off set next years gains.
I don't know I always guess wrong . I'll wait until there is news on an update which should be out soon on
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
which was completed end of Sept ,but only a phase one study .